Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7100
-0.0201 (-2.75%)
May 14, 2025, 9:33 AM - Market open
Palisade Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 7.23 | 9.82 | 12.43 | 12.38 | 10.5 | 0.71 | Upgrade
|
Short-Term Investments | - | 0.01 | - | - | - | 0.02 | Upgrade
|
Cash & Short-Term Investments | 7.23 | 9.83 | 12.43 | 12.38 | 10.5 | 0.73 | Upgrade
|
Cash Growth | -35.88% | -20.91% | 0.40% | 17.99% | 1339.64% | -79.73% | Upgrade
|
Other Receivables | - | 0.02 | 0.15 | 1.44 | 0.15 | 0.06 | Upgrade
|
Receivables | - | 0.02 | 0.15 | 1.44 | 0.15 | 0.06 | Upgrade
|
Prepaid Expenses | 0.66 | 0.56 | 0.64 | 0.8 | 0.86 | 0.07 | Upgrade
|
Other Current Assets | - | 0.08 | 0.11 | 0.11 | - | 0.04 | Upgrade
|
Total Current Assets | 7.89 | 10.49 | 13.33 | 14.73 | 11.51 | 0.9 | Upgrade
|
Property, Plant & Equipment | 0.06 | 0.09 | 0.21 | 0.31 | 0.11 | 0.28 | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | - | 1.82 | Upgrade
|
Other Long-Term Assets | 0.25 | 0.3 | 0.52 | 0.72 | 0.89 | 0.03 | Upgrade
|
Total Assets | 8.19 | 10.88 | 14.05 | 15.76 | 12.51 | 3.02 | Upgrade
|
Accounts Payable | 0.75 | 1.11 | 0.7 | 1.76 | 1.32 | 2.54 | Upgrade
|
Accrued Expenses | 1.97 | 1.96 | 1.61 | 1.06 | 0.97 | 4.33 | Upgrade
|
Current Portion of Long-Term Debt | - | 0.08 | 0.16 | 0.09 | 0.09 | 1.05 | Upgrade
|
Current Portion of Leases | 0.06 | 0.09 | 0.12 | 0.11 | 0.11 | 0.17 | Upgrade
|
Total Current Liabilities | 2.78 | 3.24 | 2.59 | 3.01 | 2.5 | 8.08 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.09 | Upgrade
|
Long-Term Leases | - | - | 0.09 | 0.21 | - | 0.11 | Upgrade
|
Other Long-Term Liabilities | 0.08 | 0.15 | 0.06 | 0.06 | 2.65 | 1.83 | Upgrade
|
Total Liabilities | 2.86 | 3.39 | 2.74 | 3.28 | 5.15 | 10.12 | Upgrade
|
Common Stock | 0.04 | 0.03 | 0.01 | 0.03 | 0 | 0.03 | Upgrade
|
Additional Paid-In Capital | 143.46 | 143.41 | 132.81 | 121.64 | 102 | 51.4 | Upgrade
|
Retained Earnings | -138.17 | -135.94 | -121.51 | -109.19 | -94.64 | -68.03 | Upgrade
|
Total Common Equity | 5.33 | 7.49 | 11.31 | 12.48 | 7.36 | -16.6 | Upgrade
|
Shareholders' Equity | 5.33 | 7.49 | 11.31 | 12.48 | 7.37 | -7.1 | Upgrade
|
Total Liabilities & Equity | 8.19 | 10.88 | 14.05 | 15.76 | 12.51 | 3.02 | Upgrade
|
Total Debt | 0.06 | 0.17 | 0.37 | 0.4 | 0.2 | 1.42 | Upgrade
|
Net Cash (Debt) | 7.17 | 9.66 | 12.06 | 11.98 | 10.3 | -0.69 | Upgrade
|
Net Cash Growth | -35.35% | -19.89% | 0.70% | 16.35% | - | - | Upgrade
|
Net Cash Per Share | 2.96 | 6.82 | 26.45 | 204.12 | 826.06 | - | Upgrade
|
Filing Date Shares Outstanding | 4.8 | 4.4 | 0.85 | 0.3 | 0.02 | 102.04 | Upgrade
|
Total Common Shares Outstanding | 4.4 | 2.77 | 0.62 | 0.2 | 0.02 | 102.04 | Upgrade
|
Working Capital | 5.11 | 7.26 | 10.74 | 11.72 | 9.01 | -7.19 | Upgrade
|
Book Value Per Share | 1.21 | 2.71 | 18.30 | 63.57 | 387.81 | -0.16 | Upgrade
|
Tangible Book Value | 5.33 | 7.49 | 11.31 | 12.48 | 7.36 | -16.6 | Upgrade
|
Tangible Book Value Per Share | 1.21 | 2.71 | 18.30 | 63.57 | 387.81 | -0.16 | Upgrade
|
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.